AI & Longevity

Margaretta Colangelo in conversation with Richard Siow, John Shepherd, and Alexander Zhavoronkov

Margaretta Colangelo, Co-founder / Managing Partner, Deep Knowledge Ventures / Longevity.Capital / Deep Knowledge Analytics

Uncovering the heterogeneity & etiology of aging

Joseph Geraci, CEO and co-Founder, NetraMark Corp

From cells to cities

Tina Woods, CEO and Founder, Longevity International

AI enables a holistic approach to Superlongevity

Ben Goertzel, Chief Scientist, Chairman, AI Researcher: SingularityNET, Novamente LLC, Humanity+

Using AI to decode and encode the signals from the brain to the body

Oliver Armitage, Co-Founder & CSO, BIOS Health

‘AI & Longevity’ Ask Me Anything

Various speakers from the conference come together to answer your questions on AI & Longevity.

Latest articles

Building an artificial immune system

DoD-funded ThirdLaw Technologies to harness the power of ‘spiroligomers’ to rapidly build new small molecules for Longevity therapies. Far from the world of stock market...

Neurotech is the new blue ocean

Alon Braun, Co-Founder, Neurotech Analytics.

Amazon and K4Connect demonstrate scalability for agetech

Covid-19 has been difficult for everyone, but particularly for people over the age of 65 who may spend months shut away from loved ones...

“Avoid the use of DQ as a senolytic therapy”

Forever Healthy Foundation issues risk-benefit analysis on dasatinib + quercetin as a senolytic. The Forever Healthy Foundation today published its latest risk-benefit analysis, which explores...